Infinity Pharmaceuticals Inc $10.94

down 0.00


22/8/2014 04:00 PM  |  NASDAQ : INFI  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get INFI Trend Analysis - it has underperformed the S&P 500 by 63%

Partner Headlines

  1. 3 Small-Cap Biotechs That Institutions Are Loving

    Benzinga
  2. UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals On ...

    Benzinga
  3. The Top Five Drug Launches Of 2013

    IBD
  4. UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on Limited Clinical ...

    Benzinga
  5. Benzinga's Top Downgrades

    Benzinga
  6. Celgene's stock hits new high

    IBD
  7. Mid-Day Market Update: Sysco Shares Rise Following Merger with US Foods; ...

    Benzinga
  8. Celgene, Infinity Rise On Blood Cancer Drug Data

    IBD
  9. Benzinga's Volume Movers

    Benzinga
  10. Infinity Reports Encouraging Phase 1 IPI-145 Data at ASH

    Benzinga
  11. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ASH

    Benzinga
  12. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ASH 2013

    Benzinga
  13. UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals on ...

    Benzinga
  14. Benzinga's Top Initiations

    Benzinga
  15. The Best Small Cap Performers of 2012

    Benzinga
  16. Stocks Hitting 52-Week Highs

    Benzinga
  17. Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma

    Benzinga
  18. Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium

    Benzinga
  19. Infinity Announces Closing of Public Offering and Exercise of Over-Allotment ...

    Benzinga
  20. Stocks Hitting 52-Week Highs

    Benzinga
  21. Infinity Pharma Prices 5.696M Shares at $26.33

    Benzinga
  22. Mid-Afternoon Market Update: Markets Continue to Rise, Diamond Foods Falls

    Benzinga
  23. Infinity Pharma Shares Rebound Over $22 Following Phase I Data on IPI-145

    Benzinga
  24. UPDATE: Jefferies Downgrades Infinity Pharmaceuticals to Hold on Limited ...

    Benzinga
  25. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  26. Stocks Hitting 52-Week Highs

    Benzinga
  27. UPDATE: Stifel Nicolaus Initiates Infinity Pharmaceuticals at Hold; Royalty ...

    Benzinga
  28. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  29. Health Care Sector Wrap

    FoxBusiness
  30. Synacor, American Capital Mortgage Investment Crp, Other Stocks Hit 52-Week ...

    FoxBusiness
  31. Infinity Pharmaceuticals Shuts Down Cancer Trials

    Benzinga
  32. Morning Market Losers

    Benzinga
  33. Benzinga's Top Pre-Market Losers

    Benzinga
  34. A Peek Into The Market Before The Trading Starts

    Benzinga
  35. UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  36. Infinity Plummets on Disappointing Phase 2 Study

    Benzinga
  37. Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  38. Infinity Reports Update from Phase 2 Study of Saridegib Plus Gemcitabine ...

    Benzinga
  39. Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients ...

    Benzinga
Trading Center